Literature DB >> 3665335

Bias in pharmacokinetics and clinical pharmacology.

E J Ariëns1, E W Wuis.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 3665335     DOI: 10.1038/clpt.1987.163

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  15 in total

1.  Racemic therapeutics--ethical and regulatory aspects.

Authors:  E J Ariëns
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Clinical pharmacology through the looking glass: reflections on the racemate vs enantiomer debate.

Authors:  M S Lennard
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

3.  Use of organic modifiers to enhance chiral selectivity in capillary electrophoresis.

Authors:  T J Ward; M Nichols; L Sturdivant; C C King
Journal:  Amino Acids       Date:  1995-12       Impact factor: 3.520

Review 4.  Bioequivalence: issues and options.

Authors:  K K Midha; M J Rawson; J W Hubbard
Journal:  J Pharmacokinet Biopharm       Date:  1997-12

Review 5.  Chirality. Clinical pharmacokinetic and pharmacodynamic considerations.

Authors:  E J Lee; K M Williams
Journal:  Clin Pharmacokinet       Date:  1990-05       Impact factor: 6.447

6.  Stereoselective drug disposition: potential for misinterpretation of drug disposition data.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

7.  Stereoselectivity, a natural aspect of molecular biology: a blind spot in clinical pharmacology and pharmacokinetics.

Authors:  E J Ariëns
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

8.  Proposal for a New Stereochemically Informative Nonproprietary Drug Naming System.

Authors:  Joseph Gal
Journal:  Pharmaceut Med       Date:  2020-04

9.  The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis.

Authors:  M A Young; L Aarons; S Toon
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.

Authors:  R Donnelly; G J Macphee
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.